The benefits of nonpharmacologic therapy for infant GERD.
Modification of feeding practices and positioning, along with tobacco smoke avoidance, can greatly reduce infant symptoms of gastroesophageal reflux disease (GERD), according to a recent report.
These findings were demonstrated in 37 infants recruited from five US outpatient general pediatric sites who were diagnosed clinically with GERD and had an abnormal score on the parent-completed Infant Gastroesophageal Reflux Questionnaire Revised (I-GERQ-2). The 12-item questionnaire pertains to regurgitation, crying, feeding refusal, apnea/cyanosis, hiccups, and arching. Each site's study nurse counseled parents on conservative measures that might improve these symptoms.
Two weeks after being counseled, parents returned to the sites with their infants to undergo assessments. I-GERQ-2 scores had improved for 78% of infants after undergoing recommended conservative therapy. In fact, scores were normal for 24% of them. Improvement was particularly significant for symptoms related to regurgitation, crying, and arching (Orenstein SR et al: J Pediatr 2008;152:310).
I like this approach to GERD: clinical diagnosis without invasive procedures, and symptomatic treatment without medication. If the patient fails to improve with these measures, a more aggressive plan might be warranted. But if these findings are correct, this next step will be unnecessary for many young patients.
Hematocrit levels in newborns: EPP vs DCC study reveals surprising findings
November 15th 2023A recent study in JAMA Network Open investigates the impact of extrauterine placental perfusion versus delayed cord clamping on hematocrit levels in newborns, shedding light on potential alternatives for optimizing infant outcomes during birth.
Preterm infant HRQOL: Long-term impacts and determinants
October 21st 2023A recent study was highlighted at the 2023 American Academy of Pediatrics National Conference & Exhibition that shed light on the long-term impact of very preterm birth on the health-related quality of life (HRQOL) of infants and identified key determinants.
Associations between prenatal metal mixture exposure and negative infant outcomes
September 19th 2023Francheska M. Merced-Nieves, PhD, Assistant professor, Departments of Pediatrics and the Institute for Exposomic Research of Environmental Medicine & Public Health, Icahn School of Medicine at Mount Sinai, explains the associations prenatal exposure to a metal mixture and the potential negative effects for the infant.
Oral vs intravenous acetaminophen: Which is better for closing a patent ductus arteriosus?
August 2nd 2023In the 18 studies that assessed the efficacy of closing a patent ductus arteriosus after 1 course of acetaminophen treatments, the results demonstrated that both oral and IV preparations were more effective than placebo.